References
Fernandes CJ, Akamine N, Knobel E: Cardiac troponin: a new serum marker of myocardial injury in sepsis. Intensive Care Med 1999, 25: 1165-1168. 10.1007/s001340051030
Wiggers CJ: Myocardial depression in shock. A survey of cardio dynamic studies. Am Heart J 1947, 33: 633-650. 10.1016/0002-8703(47)90079-3
Parker MM, Shelhamer JH, et al.: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984, 100: 483-490.
Bernard G, et al.: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344: 699. 10.1056/NEJM200103083441001
Ungureanu-Longrois D, et al.: Myocardial contractile dysfunction in systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide sintetase in cardiac myocytes. J Moll Cell Cardiol 1995, 27: 155.
Parrillo JE, et al.: A circulating myocardial depressant substance in human with septic shock. J Clin Invest 1985, 76: 1539.
Reilly JM, et al.: A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion in patients with septic shock. Chest 1989, 95: 1072.
Kumar A, et al.: Tumor necrosis factor alpha and interleukin 1 beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 1996, 183: 949. 10.1084/jem.183.3.949